Work

Obinutuzumab May Be an Effective and Safe Option for Adult Minimal Change Disease and Focal Segmental Glomerulosclerosis Patients after Multitarget Therapy Including Rituximab

Year: 2024

Type: article

Study design: Observational Study

Source: American Journal of Nephrology

DOI: 10.1159/000541972

Authors: Yuxin Lin, Yixuan Pan, Quan Han, Jianhang Xu, Junni Wang, Xin Lei, Liangliang Chen, Yaomin Wang, Pingping Ren, Lan Lan, Jianghua Chen, Fei Han

Institutions: First Affiliated Hospital Zhejiang University, Zhejiang University

Language: English

Topic: Renal Diseases and Glomerulopathies

Subfield: Nephrology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4403319831

FWCI: 3.44

Cites: 26

Cited by: 14

Related to: 10